Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Vardenafil

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44338   clinical trials with a EudraCT protocol, of which   7368   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    30 result(s) found for: Vardenafil. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2006-001002-83 Sponsor Protocol Number: IDT.ES.LEV.12006 Start Date*: 2006-06-06
    Sponsor Name:Hospital Clinico San Carlos, Unidad de Investigacion Cardiovascular
    Full Title: Pilot study to evaluate the effect of vardenafil treatment on the proteomic pattern of mononuclear cells and serum proteins in patients with erectile dysfunction and mellitus diabetes.
    Medical condition: Erectile Dysfuntion
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-005282-37 Sponsor Protocol Number: IDT.LM.LEV.22004-LEMDE Start Date*: 2005-05-24
    Sponsor Name:QUIMICA FARMACEUTICA BAYER, S.A.
    Full Title: Double-blind, cross-over, placebo-controlled pilot study to characterize the profile of those patients with traumatic spinal cord injury diagnosed by electrophysiological, urodynamic and clinical (...
    Medical condition: Erectile dysfunction (ED)
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2007-004150-85 Sponsor Protocol Number: HINEF: PDE5 Start Date*: 2008-04-11
    Sponsor Name:Charité Universitaetsmedizin Berlin
    Full Title: Cardiac failure with normal ejection fraction: possible role of phosphodiesterase type 5 inhibitors
    Medical condition: Patients with cradiac failure and normal ejection fraction
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-003761-33 Sponsor Protocol Number: IDT.ES.LEV.12004-EMDE Start Date*: 2005-02-17
    Sponsor Name:Unidad de Neuroinmunología
    Full Title: Unicenter double-blind, cross-over, randomised, placebo controlled clinical trial to evaluate efficacy of vardenafil in subjects with E.D. and multiple sclerosis (M.S.)
    Medical condition: Erectile Dysfunction
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2005-000295-41 Sponsor Protocol Number: Ro-002/05 Start Date*: 2006-05-29
    Sponsor Name:Universität zu Köln
    Full Title: Double-blind,placebo-controlled cross-over study for evaluation of the efficacy of the PDE-5-inhibitor vardenafil on the peripheral perfusion and the clinical symptomatology of patients with Raynau...
    Medical condition: Raynaud´s disease (RD) is defined as episodic, painful, cold- or emotional stress-triggered vasospasms of the digital arteries and precapillary arterioles for up to 30 minutes with or without under...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-004633-15 Sponsor Protocol Number: BAY38-9456/12496 Start Date*: 2007-01-24
    Sponsor Name:BAYER Vital GmbH
    Full Title: A randomized, double-blind, parallel group prospective pilot study to assess the effect of vardenafil on clinical outcome and on procedure duration after green light laser-ablation of the prostate ...
    Medical condition: The objective of this study is to compare the impact of vardenafil application vs. placebo on green light laser ablation of the prostate in patients presenting with benign prostate hyperplasia.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10023925 Laser prostatectomy LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-002140-41 Sponsor Protocol Number: 13171 Start Date*: 2008-11-11
    Sponsor Name:Bayer HealthCare AG
    Full Title: Double-blind, placebo controlled, randomized study of vardenafil to determine efficacy on Erectile Dysfunction (ED) in men with ED and Metabolic Syndrome ("ED-METABOLIC")
    Medical condition: The objective of this study is to determine efficacy, tolerability and safety of vardenafil on Erectile Dysfunction (ED) in men with ED and Metabolic Syndrome.
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-000463-29 Sponsor Protocol Number: BAY 38-9456 / 12049 Start Date*: 2006-08-07
    Sponsor Name:Bayer Healthcare AG
    Full Title: Evaluation of vardenafil for the treatment of subjective tinnitus: A controlled pilot study
    Medical condition: chronic tinnitus
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-022138-10 Sponsor Protocol Number: FI.LU.VA Start Date*: 2010-07-28
    Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI
    Full Title: A SINGLE-CENTRE, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY TO ASSESS SAFETY AND EFFICACY OF COMBINATION THERAPY WITH VARDENAFIL 10 mg AND TAMSULOSIN 0,4 mg IN THE TREATMENT OF MEN WITH PER...
    Medical condition: men with persistent irritative urinary symptoms
    Disease: Version SOC Term Classification Code Term Level
    13.1 10038359 - Renal and urinary disorders 10005034 Bladder discomfort PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-023420-25 Sponsor Protocol Number: Vardenafilinlivercirrhosis Start Date*: 2011-08-11
    Sponsor Name:Med. Univ. Wien, Univ. Klinik für Innere Medizin III, Abt. Gastroenterologie und Hepatologie
    Full Title: Safety and efficacy of vardenafil in patients with liver cirrhosis. A randomized controlled trial.
    Medical condition: Der Zweck dieser Studie ist es, erektile Dysfunktion bei Patienten mit Leberzirrhose mit Betablocker-Therapie zu untersuchen. Eingeschlossen werden Patienten der Abteilung für Gastroenterologie und...
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-002172-42 Sponsor Protocol Number: Bay 38-9456/11336 Start Date*: 2005-02-09
    Sponsor Name:Bayer Oy
    Full Title: A randomized, double-blind, double-dummy, multi-center, parallel group study to compare the tolerability and efficacy of once daily vardenafil versus vardenafil PRN versus placebo in men immediatel...
    Medical condition: Erektiohäiriö
    Disease: Version SOC Term Classification Code Term Level
    10061461
    Population Age: Adults Gender: Male
    Trial protocol: FI (Completed) SE (Completed) DE (Completed) AT (Completed) GB (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2010-020122-18 Sponsor Protocol Number: BAY 98-7081/14694 Start Date*: 2010-07-23
    Sponsor Name:Bayer HealthCare AG
    Full Title: A prospective, randomized, double-blind, double-dummy, placebo- and active controlled, multicenter study assessing the efficacy and safety of the combination BAY 60 4552 / vardenafil compared to va...
    Medical condition: Erectile dysfunction
    Disease: Version SOC Term Classification Code Term Level
    12.1 10061461 Erectile dysfunction LLT
    Population Age: Adults Gender: Male
    Trial protocol: FR (Completed) DE (Completed) NL (Completed) FI (Completed) ES (Completed) IT (Completed) SE (Completed)
    Trial results: View results
    EudraCT Number: 2006-001228-37 Sponsor Protocol Number: BAY38-9456/12146 Start Date*: 2006-07-13
    Sponsor Name:Bayer HealthCare AG, D-51368 Leverkusen
    Full Title: A randomized, double blind, parallel group study of vardenafil flexible dose versus placebo in males with erectile dysfunction and their female partners’ sexual quality of life. PARTNER II
    Medical condition: Males with Erectile Dysfunction
    Disease: Version SOC Term Classification Code Term Level
    8.1 10061461 Erectile dysfunction LLT
    Population Age: Adults Gender: Male
    Trial protocol: NL (Completed) ES (Completed) BE (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005145-11 Sponsor Protocol Number: BAY 38-9456 / 12392 Start Date*: 2007-07-27
    Sponsor Name:Bayer Healthcare AG
    Full Title: Randomized, double-blind, placebo-controlled, parallel group study of vardenafil 10 mg twice daily to assess the effect on urodynamics in patients with Overactive Bladder (detrusor overactivity).
    Medical condition: Overactive bladder (detrusor overactivity)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10059617 Overactive bladder LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) FR (Completed) PT (Completed) ES (Completed) HU (Completed) CZ (Completed) BE (Completed) NL (Completed)
    Trial results: View results
    EudraCT Number: 2005-002796-32 Sponsor Protocol Number: BAY 38-9456 / 11863 Start Date*: 2005-10-17
    Sponsor Name:Bayer Healthcare AG
    Full Title: A randomized, double-blind, placebo-controlled, multi-center, parallel group study to assess the efficacy of vardenafil in the treatment of symtomatic Benign Prostatic Hyperplasia
    Medical condition: Benigne Prostatic Hyperplasia
    Disease: Version SOC Term Classification Code Term Level
    8.0 10004446 LLT
    Population Age: Adults Gender: Male
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-014137-25 Sponsor Protocol Number: VARDENAFIL&DIABETES Start Date*: 2009-12-15
    Sponsor Name:Unita` Operativa di Endocrinologia e Malattie del Metabolismo
    Full Title: Monitoring of endothelial dysfunction during chronic administration of vardenafil in patients with type 2 diabetes mellitus: A longitudinal, randomised, placebo-controlled, double blind, phase II b...
    Medical condition: patients affected by type 2 Diabetes mellitus and affected by mild or severe ED
    Disease: Version SOC Term Classification Code Term Level
    12.0 10045248 Type II diabetes mellitus with other specified manifestations LLT
    Population Age: Adults Gender: Male
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-001678-28 Sponsor Protocol Number: BAY 38-9456 / IMPACT 11875 Start Date*: 2005-09-15
    Sponsor Name:Bayer Healthcare AG
    Full Title: A randomized, explorative, double-blind, double-dummy, multi-center, parallel group study to assess sustainable efficacy of once daily vardenafil (10 mg) for 12 and 24 weeks versus vardenafil PRN i...
    Medical condition: Erectile Dysfunction
    Disease: Version SOC Term Classification Code Term Level
    10061461
    Population Age: Adults Gender: Male
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005239-32 Sponsor Protocol Number: PDE5 Start Date*: 2006-11-28
    Sponsor Name:Medical Sciences, Akademiska sjukhuset
    Full Title: Fosfodiesterashämmares akuta hemodynamiska effekter vid pulmonell hypertension och utvärdering av kväveoxid mätningar som icke-invasiv diagnostisk metod
    Medical condition:  Pulmonell hypertension med kvarstående förhöjt medeltryck i arteria pulmonalis överstigande 25 mmHg i vila eller >30 mmHg under ansträngning vid hjärtkateterisering definierad av National Institu...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-020018-27 Sponsor Protocol Number: Dbox2008/01978 Start Date*: 2012-04-19
    Sponsor Name:Tameside Hospital NHS Foundation Trust
    Full Title: Effect of Testosterone on endothelial function and Microcirculation in Type 2 Diabetic patients with Hypoganadism.
    Medical condition: Hypogonadism and erectile dysfunction in patients with type 2 diabetes
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-001770-25 Sponsor Protocol Number: IDT.ES.LEV.22006 Start Date*: 2006-08-13
    Sponsor Name:Dr Antoni Gual, Hospital Clínic de Barcelona, Unitat d'Alcohologia de la Generalitat de Catalunya
    Full Title: Ensayo clínico unicéntrico, cruzado, aleatorizado, doble ciego, controlado con placebo, para evaluar la calidad de la vida sexual en pacientes alcohólicos afectados de DE tras un tratamiento con va...
    Medical condition: Disfunción Eréctil / Erectile Dysfunction
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 24 15:41:45 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA